The Cannabis Use Problems Identification Test (CUPIT): Development, reliability, concurrent and predictive validity among adolescents and adults

Addiction

Volumn 105, Issue 4, 2010, Pages 615-625

  Bashford, Jan ^a   Flett, Ross ^a   Copeland, Jan ^b  

^a MASSEY UNIVERSITY   (New Zealand)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cannabis problems; Cannabis screening; Psychometrics; Public health

Indexed keywords

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CANNABIS ADDICTION; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HOSPITALIZATION; HUMAN; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOMETRY; PUBLIC HEALTH; QUESTIONNAIRE; REPRODUCIBILITY; SELF EVALUATION; STANDARD; VALIDATION STUDY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MARIJUANA ABUSE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMETRICS; PUBLIC HEALTH; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF ASSESSMENT (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77949364471     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02859.x     Document Type: Article

References (68)

1. UNODC 2009). World Drug Report 2009. Available at: http://www.unodc.org (accessed 25 July 2009).
2. Fergusson D. M., Horwood L. J. Cannabis use and dependence in a New Zealand birth cohort. NZ Med J 2000 113 : 156 158.
3. World Health Organization. The Neuroscience of Psychoactive Substance Use and Dependence. Geneva : Author 2004.
4. World Health Organization. Alcohol, drugs, and tobacco programme. World Health Organization Phase III Collaborative Study on implementing and supporting early intervention strategies in primary care. Report on Strand I: General practitioner current practices and perceptions of preventive medicine and early intervention for hazardous alcohol use. A 16-country study. Copenhagen, Denmark : WHO 1998.
5. Lader M., Edwards G., Drummond D. C. The demands which the problems perspective sets for research. In : Lader M., Edwards G., Drummond D. C., editors. The Nature of Alcohol and Drug-Related Problems. New York : Oxford University Press 1992, p. 189 197.
6. Anthony J. C. Putting epidemiology and public health in needs assessment: drug dependence and beyond. In : Andrews G., Henderson S., editors. Unmet Need in Psychiatry: Problems, Resources, Responses. Cambridge : Cambridge University Press 2000, p. 302 308.
7. Hall W., Swift W. Policy implications of cannabis dependence. In : Roffman R. A., Stephens R. S., editors. Cannabis Dependence: Its Nature, Consequences and Treatment. London : Cambridge University Press 2006, p. 315 319.
8. Penrose-Wall J., Copeland J., Harris M. Shared Care of Illicit Drug Problems by General Practitioners and Primary Health Care Providers: a Literature Review. Sydney : Centre for General Practice Integration Studies, University of New South Wales 2000.
9. Copeland J., Frewen A., Elkin K. Management of Cannabis Use Disorder and Related Issues: a Clinician's Guide. Sydney : National Cannabis Prevention and Information Centre (NCPIC).
10. McPherson T. L., Hersch R. K. Brief substance use screening instruments for primary care settings: a review. J Subst Abuse Treat 2000 18 : 193 202.
11. Fleming M. Screening, assessment, and intervention for substance use disorders in general health care settings. Subst Abuse 2002 23 : 47 66.
12. Hannifin J. The cannabis abuse syndrome screening test: a brief report. Unpublished report. Wellington: Drugs Advisory Committee 1990.
13. Adamson S., Sellman J. D. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol dependent clinical sample. Drug Alcohol Rev 2003 22 : 309 315.
14. Alexander D. A Marijuana Screening Inventory (experimental version): description and preliminary psychometric properties. Am J Drug Alcohol Abuse 2003 29 : 619 646.
15. Alexander D., Leung P. The Marijuana Screening Inventory (MSI-X): reliability, factor structure, and scoring criteria with a clinical sample. Am J Drug Alcohol Abuse 2004 30 : 321 351.
16. Alexander D., Leung P. The Marijuana Screening Inventory (MSI-X): concurrent, convergent and discriminant validity with multiple measures. Am J Drug Alcohol Abuse 2006 32 : 351 378.
17. Legleye S., Karila L., Beck F., Reynaud M. Validation of the CAST, a general population Cannabis Abuse Screening Test. J Subst Use 2007 12 : 233 242.
18. Okulicz-Kozaryn K. Psychometric properties of the Problematic Marijuana Use (PUM) test for adolescents. Post Psychiatry Neurol 2007 16 : 105 111.
19. Piontek D., Kraus L., Klempova D. Short scales to assess cannabis-related problems: a review of psychometric properties. Subst Abuse Treat Prev Policy 2008 3 : 25.
20. Likert R. A technique for the measurement of attitudes. Arch Psychol 1932 140 : 44 53.
21. Griffiths P., Gossop M., Powis B., Strang J. Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction 1993 88 : 1617 1626.
22. Watters J., Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl 1989 36 : 416 430.
23. Sobell L. C., Sobell M. B. Timeline Follow-Back: a technique for assessing self-reported alcohol consumption. In : Litten R., Allen J., editors. Measuring Alcohol Consumption; Psychosocial and Biochemical Methods. Totowa, NJ : Humana Press Inc 1992, p. 41 69.
24. Sobell L. C., Sobell M. B., Buchan G., Cleland P. A., Leo G. I. The reliability of the timeline followback method applied to drug, cigarette, and cannabis use. Paper presented at the 30th Annual Meeting of the Association for Advancement of Behavior Therapy, New York, November 1996.
25. Fals-Stewart W., O'Farrell T. J., Freitas T. T., McFarlin S. K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000 68 : 134 144.
26. Marijuana Treatment Project Research Group. Brief treatments for cannabis dependence: findings from a randomized multi-site trial. J Consult Clin Psychol 2004 72 : 455 456.
27. Leino A., Saaramies J., Gronholm M., Lillesunde P. Comparison of eight commercial on-site screening devices for drugs of abuse testing. Scand J Clin Lab Invest 2001 61 : 325 331.
28. Lafolie P., Beck O., Blennow G., Boreus L., Borg S., Elwin C. E. et al. Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem 1991 37 : 1927 1931.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington : Author 1994.
30. World Health Organization. International Classification of Diseases-Tenth Revision (ICD-10). Geneva : Author 1992.
31. World Health Organization. Composite International Diagnostic Interview, 2.1, Computerized Version (CIDI-Auto). Geneva : Author 1997.
32. Andrews G., Peters L. The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol 1998 33 : 80 8.
33. Rubio-Stipec M., Peters L., Andrews G. Test-retest reliability of the computerized CIDI (CIDI-Auto): substance abuse modules. Subst Abuse 1999 20 : 263 272.
34. Wittchen H.-U., Lachner G., Wunderlich U., Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998 33 : 568 578.
35. Kedzior K. K., Martin-Iverson M. T. Concurrent validity of cannabis misuse on CIDI-Auto 2.1 in low-level cannabis users from the general population. Aust J Psychol 2007 59 : 169 175.
36. Swift W., Copeland J., Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998 93 : 1681 1692.
37. Martin G., Copeland J., Gates P., Gilmour S. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users. J Subst Abuse Treat 2006 29 : 207 213.
38. Copeland J., Swift W., Roffman R., Stephens R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treat 2001 21 : 55 64.
39. Copeland J., Gilmour S., Gates P., Swift W. The Cannabis Problems Questionnaire: factor structure, reliability and validity. Drug Alcohol Depend 2005 80 : 313 319.
40. Martin G., Copeland J., Gilmour S., Gates P., Swift W. The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties. Addict Behav 2006 31 : 2238 2248.
41. Derogatis L. R. Brief Symptom Inventory 18 (BSI 18): Administration, Scoring, and Procedures Manual. Minneapolis, MN : National Computing Systems Pearson, Inc 2000.
42. Derogatis L. R. Symptom Checklist 90-R (SCL-90-R): Administration, Scoring, and Procedures Manual, 3rd edn. Minneapolis, MN : National Computing Systems Pearson, Inc 1994.
43. SPSS, Inc. SPSS Base 12.0. User's Guide. Chicago, IL : Author 2003.
44. Cronbach L. J. Coefficient alpha and the internal structure of tests. Psychometrika 1951 16 : 297 334.
45. Comrey A. L., Lee H. B. A First Course in Factor Analysis. Hillsdale, NJ : Lawrence Erlbaum Associates 1992.
46. Nunnally J. C. Psychometric Theory. New York : McGraw-Hill Inc 1978.
47. Deas D., Roberts J., Grindlinger D. The utility of DSM-IV criteria in diagnosing substance abuse/dependence in adolescents. J Subst Use 2005 10 : 10 21.
48. Degenhardt L., Lynskey M., Coffey C., Patton G. 'Diagnostic orphans' among young adult cannabis users: persons who report symptoms but do not meet diagnostic criteria. Drug Alcohol Depend 2002 67 : 205 212.
49. Cattell R. B. The screen test for number of factors. Multivariate Behav Res 1966 1 : 245 276.
50. Kim J.-O., Mueller C. W. Factor Analysis: Statistical Methods and Practical Issues. Beverly Hills, CA : Sage 1978.
51. Schmitt N. Uses and abuses of coefficient alpha. Psychol Assess 1996 8 : 350 353.
52. Kline P. The New Psychometrics: Science, Psychology, and Measurement. London : Routledge 1998.
53. Streiner D. L., Norman G. R., editors. Health Measurement Scales: a Practical Guide to Their Development and Use, 2nd edn. Oxford : Oxford University Press 1995.
54. Saunders J. B., Aasland O. G., Amunsden A., Grant M. Development of the Alcohol Use Disorders Indentification Test (AUDIT): WHO collaborative project on Early Detection of Persons with Harmful Alcohol Consumption: II. Addiction 1993 88 : 791 804.
55. Dawe S., Loxton N. J., Hides L., Kavanagh D. J., Mattick R. P. Review of Diagnostic Screening Instruments for Alcohol and Other Drug Use and Other Psychiatric Disorders, 2nd edn. Canberra : Australian Government Publishing Service 2002.
56. Newcombe D. A. L., Humeniuk R. E., Ali R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST); report of results from the Australian site. Drug Alcohol Rev 2005 24 : 217 226.
57. Winters K. Assessment of alcohol and other drug use among adolescents. In : Allen J., Wilson V. B., editors. Assessing Alcohol Problems, 2nd edn. NIH Publication no. 03-3745. Bethseda, MD : National Institute on Alcohol Abuse and Alcoholism 2003.
58. Hasin D., Paykin A. Dependence symptoms but no diagnosis: 'diagnostic orphans' in a 1992 national sample. Drug Alcohol Depend 1999 53 : 215 222.
59. Chen C.-Y., O'Brien M. S., Anthony J. C. Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. Drug Alcohol Depend 2005 79 : 11 22.
60. Degenhardt L., Coffey C., Carlin J. B., Swift W., Patton G. C. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria. Drug Alcohol Depend 2008 92 : 86 90.
61. Conigrave K. M., Hall W., Saunders J. B. The AUDIT questionnaire: choosing a cut-off score. Addiction 1995 90 : 1349 1356.
62. Babor T. F., Steinberg K., McRee B., Vendetti J., Carroll K. C. Treating marijuana dependence in adults: a multi-site randomized clinical trial. New Dir Eval 2002 94 : 17 30.
63. Buchan B. J., Dennis M. L., Tims F. M., Diamond G. S. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 2002 97 : 98 108.
64. Gignac M., Wilens T. E., Biederman J., Kwon A., Mick E., Swezey A. Assessing cannabis use in adolescents and young adults: what do urine screens and parental report tell you? J Child Adolesc Pharmacol 2005 15 : 742 750.
65. Mennes C. E., Abdallah A. B., Cottler L. B. The reliability of self-reported cannabis abuse, dependence and withdrawal symptoms: multisite study of differences between general population and treatment groups. Addict Behav 2009 34 : 223 226.
66. Agosti V., Levin F. Predictors of treatment contact among individuals with cannabis dependence. Am J Drug Alcohol Abuse 2004 30 : 121 127.
67. Gates P., Taplin S., Copeland J., Swift W., Martin G. Barriers and facilitators to cannabis treatment. NCPIC Technical Report 1, NCPIC: Sydney 2009.
68. Urbanoski K. A., Strike C. J., Rush B. R. Individuals seeking treatment for cannabis-related problems in Ontario: demographic and treatment profile. Eur Addict Res 2005 11 : 115 123.